000 | 01673 a2200445 4500 | ||
---|---|---|---|
005 | 20250518094952.0 | ||
264 | 0 | _c20210302 | |
008 | 202103s 0 0 eng d | ||
022 | _a1090-2120 | ||
024 | 7 |
_a10.1016/j.bioorg.2020.103814 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHuang, Wan-Yun | |
245 | 0 | 0 |
_aPyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo. _h[electronic resource] |
260 |
_bBioorganic chemistry _c06 2020 |
||
300 |
_a103814 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 | _aCattle |
650 | 0 | 4 |
_aCell Cycle _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aDNA _xchemistry |
650 | 0 | 4 |
_aDNA Topoisomerases, Type I _xmetabolism |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMolecular Docking Simulation |
650 | 0 | 4 | _aMolecular Structure |
650 | 0 | 4 |
_aQuinazolinones _xchemical synthesis |
650 | 0 | 4 | _aStructure-Activity Relationship |
650 | 0 | 4 |
_aTopoisomerase I Inhibitors _xchemical synthesis |
650 | 0 | 4 | _aTumor Cells, Cultured |
700 | 1 | _aZhang, Xiao-Rong | |
700 | 1 | _aLyu, Liang | |
700 | 1 | _aWang, Shu-Qin | |
700 | 1 | _aZhang, Xiao-Ting | |
773 | 0 |
_tBioorganic chemistry _gvol. 99 _gp. 103814 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bioorg.2020.103814 _zAvailable from publisher's website |
999 |
_c30845435 _d30845435 |